China State Administration of Traditional Chinese Medicine Finalizes Restructuring Plan
This article was originally published in PharmAsia News
Executive Summary
China's State Administration of Traditional Chinese Medicine has received approval from the State Council for a plan to restructure its organization and personnel. SATCM will remain a state bureau directly under the Ministry of Health, taking charge of the promotion of TCM, as well as cultivating talent; however, some of its power of administrative approval will be revoked, in line with a previous announcement by the State Council, or cabinet. In addition to SATCM's existing six departments, there will be a new division of planning and finance, with responsibility for medium- and long-term TCM development planning, industry policy formulation, bureau budget, accounting, financing and asset management, key project management, and the general survey, protection and development of TCM resources. (Click here for more - Chinese Language)
You may also be interested in...
India Creates Digital Library To Protect Traditional Medicine; Taskforce Pushes To Tap Export Market
NEW DELHI - After the popularity of yoga in the Western world, the Indian government is gearing up to globally promote another piece of the traditional knowledge pie - the Indian system of medicines, which includes Ayurveda, Unani and Siddha (Ayush)
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.